Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05489601 · ClinicalTrials.gov registry record
Non-intrusive Detection of Temporary Neurologic Impairment by Opioids
A clinical trial of Neurologic Impairment by Opioids, sponsored by Zxerex Corporation.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT05489601: Completed study of Neurologic Impairment by Opioids, sponsored by Zxerex Corporation.
NCT05489601 is a study of Neurologic Impairment by Opioids that has completed, run by Zxerex Corporation. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05489601, a study of Neurologic Impairment by Opioids, has completed, sponsored by Zxerex Corporation.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to prove the feasibility of a non-invasive means to identify temporary neurological impairment resulting from the use of a commonly prescribed opioid by identifying an oculomotor biosignature associated with temporary neurologic impairment in pain-free opioid-naïve subjects, and to initiate the development of such a signature. The investigators also sought to establish the presence of a dose-dependent biosignature for opioid impairment.
Primary Outcome
Eye position over time is recorded and tracked using a specialized eye-tracking camera system during a battery of visual tests under control and oxycodone challenge conditions. This data is converted to a velocity measure as millimeters per second (mm/second) and then converted to an angular velocity as degrees of visual angle per second (dva/second).
Conditions Studied
Interventions
- DRUG Oxycodone
Study Locations (1)
Arizona
- Mayo Clinic - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2022-03-29 |
What the finished NCT05489601 record still lists
NCT05489601 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target.
The record links to 1 condition, with Neurologic Impairment by Opioids appearing as the primary indexed condition, and to 1 intervention - of which Oxycodone is the first listed.
NCT05489601 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05489601 about?
NCT05489601 is a clinical study titled "Non-intrusive Detection of Temporary Neurologic Impairment by Opioids". The investigators aim to prove the feasibility of a non-invasive means to identify temporary neurological impairment resulting from the use of a commonly prescribed opioid by identifying an oculomotor biosignature associated with temporary neurologic impairment in pain-free opioid-naïve subjects, a...
What is the current status of trial NCT05489601?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2020-02-28. Estimated completion is 2022-03-29.
What conditions does trial NCT05489601 study?
This clinical trial studies the following conditions: Neurologic Impairment by Opioids.
What interventions are being tested in trial NCT05489601?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT05489601?
This trial is sponsored by Zxerex Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05489601 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI